Biblio Discovery — Demo Discovery Service

1,162 results

Showing 1–20 · 1.11 seconds · RSS

Journal

Therapeutic Advances in Neurological Disorders

Scopus

ISSN 1756-2864 · SAGE Publishing · 1,162 articles in the index

  1. Journal Article

    Brain volume and network changes in pediatric MOGAD: A retrospective cohort study based on non-acute brain MRI

    Shangru Li; Zhihao Li; Yun Qin et al.

    Therapeutic Advances in Neurological Disorders, Vol. 19 · 2026 · English · DOAJ Scopus

    Background Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), as the most common type of pediatric central nervous system idiopathic inflammatory demyelinating diseases, has an unclear impact on brain volume and brain networks in children. Objective To investigate differences…

  2. Journal Article

    Telitacicept as add-on therapy for myasthenic crisis: A retrospective cohort study

    Jiamin Peng; Fangyi Shi; Cunzhou Shen et al.

    Therapeutic Advances in Neurological Disorders, Vol. 19 · 2026 · English · DOAJ Scopus

    Background Myasthenic crisis (MC) is a life-threatening exacerbation of myasthenia gravis (MG) that often requires mechanical ventilation (MV) and intensive care. Following acute stabilization, optimal maintenance immunotherapy remains uncertain in some patients. Objectives To evaluate the efficacy…

  3. Journal Article

    Bridging the autonomic divide: Closed-loop spinal cord stimulation as a dynamic therapy for parkinsonian orthostatic hypotension

    Jing Zhao; ZiBin Ma; ZiXin Chia et al.

    Therapeutic Advances in Neurological Disorders, Vol. 19 · 2026 · English · DOAJ Scopus

    Neurogenic orthostatic hypotension (nOH) in Parkinson’s disease (PD) represents a potential “central-peripheral disconnection” rather than an isolated peripheral deficit. Driven by progressive sympathetic denervation, this uncoupling leaves the peripheral effectors in a fragile, “sick-but-not-dead”…

  4. Journal Article

    Cladribine use for multiple sclerosis with autoimmune comorbidities: retrospective analysis of the French MS registry, case series, and therapeutic considerations

    Vito A. G. Ricigliano; Ines Masmoudi; Marine Boudot de la Motte et al.

    Therapeutic Advances in Neurological Disorders, Vol. 19 · 2026 · English · DOAJ Scopus

    Background: Autoimmune (AI) comorbidities are common in people with multiple sclerosis (MS) and may complicate therapeutic management, particularly when dual immunosuppression is required. Cladribine, an immune reconstitution therapy approved for relapsing MS, has shown potential benefit in…

  5. Journal Article

    Remote brainstem lesion associated with lower cervical spinal dural arteriovenous fistula—venous outflow bottleneck: a case report and literature review

    Yohei Takenobu; Kayoko Yukawa; Jumpei Sugiyama et al.

    Therapeutic Advances in Neurological Disorders, Vol. 19 · 2026 · English · DOAJ Scopus

    Spinal dural arteriovenous fistula (SDAVF) is an important cause of venous congestive myelopathy, as timely treatment offers the potential for neurological recovery. However, it is sometimes misdiagnosed when presenting with atypical intracranial or brainstem lesions. Although venous congestion in…

  6. Journal Article

    Residual early neurological deterioration following dual antiplatelet in stroke: post hoc analysis of the ATAMIS trial

    Yu Cui; Xiang-Ru Kong; Jing Zhang et al.

    Therapeutic Advances in Neurological Disorders, Vol. 19 · 2026 · English · DOAJ Scopus

    Background: A clinically significant proportion of patients experience early neurological deterioration (END) despite receiving dual antiplatelet therapy (DAPT) for acute ischemic stroke. It is crucial to identify this specific population for risk stratification and targeted intervention…

  7. Journal Article

    Clinical, imaging, and immunotherapeutic features in MOGAD: a retrospective real-world cohort in Northern China

    Xuetao Cao; Danqing Qin; Chunjuan Wang et al.

    Therapeutic Advances in Neurological Disorders, Vol. 19 · 2026 · English · DOAJ Scopus

    Background: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a clinically heterogeneous demyelinating disorder. Current knowledge of its phenotypic spectrum and optimal treatment strategies, especially in Asian populations, remains limited. Objectives: This study aimed to…

  8. Journal Article

    Narcolepsy with co-occurring epilepsy: diagnostic pitfalls and management strategy

    Xinyan Zhang; Mengling Zha; Jiafeng Ren et al.

    Therapeutic Advances in Neurological Disorders, Vol. 19 · 2026 · English · DOAJ Scopus

    Narcolepsy and epilepsy are chronic neurological disorders that occasionally coexist. Overlapping symptoms, such as sudden loss of muscle tone and uncertainty regarding preservation of awareness, frequently complicate accurate diagnosis and ambiguity remains regarding optimal therapeutic…

  9. Journal Article

    Single-channel EEG captures tDCS-induced changes in neural reactivity: a pilot study in disorders of consciousness patients and healthy controls

    Lior Molcho; Neta B. Maimon; Nathan Intrator et al.

    Therapeutic Advances in Neurological Disorders, Vol. 19 · 2026 · English · DOAJ Scopus

    Background: Understanding and enhancing neural recovery in disorders of consciousness (DoC) remains a critical challenge in clinical care. Clinical scales such as the Coma Recovery Scale–Revised (CRS-R) are essential, but reflect behavioral responsiveness and may not fully capture subtle…

  10. Journal Article

    Clinical heterogeneity and immunotherapy outcomes in anti-GAD65 antibody-associated autoimmune encephalitis: a retrospective study

    Yihui Qiu; Zhiheng Huang; Tengyun Ma et al.

    Therapeutic Advances in Neurological Disorders, Vol. 19 · 2026 · English · DOAJ Scopus

    Anti-glutamic acid decarboxylase 65 (GAD65) antibody-associated autoimmune encephalitis (AE) is characterized by diverse neurological manifestations and systemic autoimmune comorbidities, posing diagnostic and therapeutic challenges. This study aimed to investigate the clinical heterogeneity…

  11. Journal Article

    Complement C5 inhibitors as add-on rescue treatment in severe AQP4-antibody neuromyelitis optica spectrum disorder attacks: a case series and literature review

    Kai Xin Gan; Sarah Hasnor Binti Abu Hassan; Xiu Ling Tan et al.

    Therapeutic Advances in Neurological Disorders, Vol. 19 · 2026 · English · DOAJ Scopus

    Acute attacks of aquaporin-4 antibody neuromyelitis optica spectrum disorder (AQP4-Ab NMOSD) are typically managed with intravenous methylprednisolone, with therapeutic plasma exchange (PLEX) reserved for severe episodes. Despite these interventions, a subset of patients fails to respond and may…

  12. Journal Article

    Changes in vaccination status, willingness and knowledge in patients with multiple sclerosis: Results from a five-year longitudinal study

    Bassel Barhoum; Michael Hecker; Avinash Mohnish Suntah et al.

    Therapeutic Advances in Neurological Disorders, Vol. 19 · 2026 · English · DOAJ Scopus

    Background Multiple sclerosis (MS) is a chronic immune-mediated disease requiring long-term management. Both the disease itself and disease-modifying therapies increase susceptibility to severe infections. Ensuring adequate vaccination in patients with MS is therefore essential. However, vaccine…

  13. Journal Article

    Telitacicept for primary angiitis of the central nervous system: A real-world retrospective study

    Jiangyi Lyu; Yifan Wang; Fangfang Li et al.

    Therapeutic Advances in Neurological Disorders, Vol. 19 · 2026 · English · DOAJ Scopus

    Background Primary central nervous system vasculitis (PACNS) is a rare inflammatory disease with limited treatment options. Telitacicept and high-resolution vessel wall imaging (HR-VWI) may offer new strategies for therapy and disease monitoring. Objective To evaluate the clinical efficacy and…

  14. Journal Article

    Efficacy and safety of interleukin-6 receptor inhibitors in myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD): A systematic review and meta-analysis

    Aasim Ali MBBS; Abdullah Shahid MBBS, FCPS; Javed Iqbal FCPS, MBBS et al.

    Therapeutic Advances in Neurological Disorders, Vol. 19 · 2026 · English · DOAJ Scopus

    Background Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) can follow a relapsing course, yet evidence for effective maintenance therapy remains limited. Interleukin-6 receptor (IL-6R) inhibition has emerged as a potential relapse-prevention strategy. Objectives To evaluate…

  15. Journal Article

    Spinal muscular atrophy: Biology, pathogenesis, and therapeutic advances

    Charlotte A. René; Robin J. Parks

    Therapeutic Advances in Neurological Disorders, Vol. 19 · 2026 · English · DOAJ Scopus

    Recently instituted world-wide newborn screening programs for spinal muscular atrophy (SMA) permit identification of at-risk individuals prior to clinical presentation of the disease. Early intervention with one or more of the available disease-modifying therapies has dramatically changed the…

  16. Journal Article

    Treatment patterns, access, and multidimensional burden of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) in China: A nationwide cross-sectional study

    Yue Yu; Yuxin Fan; Han Bao et al.

    Therapeutic Advances in Neurological Disorders, Vol. 19 · 2026 · English · DOAJ Scopus

    Background Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare demyelinating disorder with evolving diagnostic and treatment landscape. Real-world evidence on treatment patterns, access, and disease burden remains limited, particularly in China. Objectives To…

  17. Journal Article

    Evaluating the cognitive efficacy of marine-derived drugs in Alzheimer’s disease: A systematic review and Bayesian network meta-analysis

    Zhaoming Song; Yun Xie; Hanmo Zhu et al.

    Therapeutic Advances in Neurological Disorders, Vol. 19 · 2026 · English · DOAJ Scopus

    Background In recent years, marine-derived drugs for Alzheimer’s disease (AD) have attracted growing attention, but their comparative cognitive efficacy and safety remain uncertain because of inconsistent findings across studies. Objectives To compare the efficacy and safety of marine-derived…

  18. Journal Article

    Relapse risk and functional outcomes in anti-LGI1 encephalitis: A multicenter retrospective analysis

    Chun-Hong Shen; Bo Jin; Ye Du et al.

    Therapeutic Advances in Neurological Disorders, Vol. 19 · 2026 · English · DOAJ Scopus

    Background Anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis presents relapse risk and potential functional impairment, with no established maintenance treatment guidelines. Objectives The study aimed to uncover prognostic signatures, and identify predictors of relapse and poor…

  19. Journal Article

    Current practices in delirium prevention and treatment after acute stroke: results of a multicentre survey

    Markus Kneihsl; Annerose Mengel; Stefan Sumerauer et al.

    Therapeutic Advances in Neurological Disorders, Vol. 19 · 2026 · English · DOAJ Scopus

    Background: Delirium affects 10–30% of acute stroke patients, is associated with poor outcomes and places a substantial burden on healthcare staff. Evidence-based prevention and treatment strategies are limited, resulting in heterogeneous and poorly standardised delirium management in acute stroke…

Showing at most 50 pages. Narrow your search with filters for more specific results.